Skip to main content

Operation of Choice for Metabolic Surgery

  • Chapter
  • First Online:

Abstract

In addition to achieving significant weight loss, bariatric/metabolic surgery causes improvement, and even complete remission, of type 2 diabetes mellitus (T2DM) in a substantial number of severely obese patients. Diabetic patients with body mass index (BMI) ≥35 kg/m2, especially those with other weight-related comorbidities and acceptable surgical risk and have not responded adequately to nonsurgical management, are candidates for metabolic surgery. Currently accepted metabolic operations include Roux-en-Y gastric bypass (RYGB), laparoscopic adjustable gastric banding (LAGB), sleeve gastrectomy (SG), biliopancreatic diversion (BPD), and the duodenal switch variant (BPD-DS). The operations differ in the degree of benefit they impart on an individual’s state of metabolic profile. The general understanding, based on the results of limited high-quality trials, suggests the presence of an antidiabetic efficacy gradient among standard operations (i.e., BPD > RYGB > SG > AGB). More extensive diversionary procedures are generally associated with greater weight loss and more profound metabolic benefits in the long term, but at the cost of more surgical complications. The choice of metabolic surgery requires precise assessment of risk versus benefit for each operation and must be individualized for each patient. Patient’s operative risk and severity of T2DM are among the main determinants in the choice of metabolic surgery. In appropriate-risk patients with prediabetes or established T2DM, RYGB is the best overall option. The recommendations of this chapter are subject to change as more comparative studies become available.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Dixon JB, Zimmet P, Alberti KG, Rubino F, International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Surg Obes Relat Dis. 2011;7(4):433–47.

    Article  PubMed  CAS  Google Scholar 

  2. Rubino F, Kaplan LM, Schauer PR, Cummings DE, Diabetes Surgery Summit Delegates. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251(3):399–405.

    Article  PubMed  Google Scholar 

  3. Dixon JB, le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet. 2012;379(9833):2300–11.

    Article  PubMed  Google Scholar 

  4. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med. 2010;61:393–411.

    Article  PubMed  CAS  Google Scholar 

  5. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–50.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Eldar S, Heneghan HM, Brethauer SA, Schauer PR. Bariatric surgery for treatment of obesity. Int J Obes (Lond). 2011;35:S16–21.

    Article  Google Scholar 

  7. Carlsson LM, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695–704.

    Article  PubMed  CAS  Google Scholar 

  8. Pories WJ. The IDF Statement: a big and long-awaited step for our diabetic patients. Obes Surg. 2011;21(10):1487–9.

    Article  PubMed  Google Scholar 

  9. Reoch J, Mottillo S, Shimony A, Filion KB, Christou NV, Joseph L, et al. Safety of laparoscopic vs open bariatric surgery: a systematic review and meta-analysis. Arch Surg. 2011;146(11):1314–22.

    Article  PubMed  Google Scholar 

  10. Shukla AP, Moreira M, Dakin G, Pomp A, Brillon D, Sinha N, et al. Medical versus surgical treatment of type 2 diabetes: the search for level 1 evidence. Surg Obes Relat Dis. 2012;8(4):476–82.

    Article  PubMed  Google Scholar 

  11. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.

    Article  PubMed  CAS  Google Scholar 

  12. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56.

    Article  PubMed  Google Scholar 

  13. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  14. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.

    Article  PubMed  CAS  Google Scholar 

  15. Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.

    Article  PubMed  CAS  Google Scholar 

  16. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Swedish Obese Subjects Study Scientific Group, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.

    Article  PubMed  Google Scholar 

  17. Adams TD, Pendleton RC, Strong MB, Kolotkin RL, Walker JM, Litwin SE, et al. Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese. Obesity. 2010;18(1):121–30.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Lee WJ, Chong K, Ser KH, Lee YC, Chen SC, Chen JC, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146(2):143–8.

    Article  PubMed  Google Scholar 

  19. Pournaras DJ, Osborne A, Hawkins SC, Vincent RP, Mahon D, Ewings P, et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg. 2010;252(6):966–71.

    Article  PubMed  Google Scholar 

  20. Pinheiro JS, Schiavon CA, Pereira PB, Correa JL, Noujaim P, Cohen R. Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients. Surg Obes Relat Dis. 2008;4(4):521–5.

    Article  PubMed  Google Scholar 

  21. Søvik TT, Aasheim ET, Taha O, Engström M, Fagerland MW, Björkman S, et al. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial. Ann Intern Med. 2011;155(5):281–91.

    Article  PubMed  Google Scholar 

  22. Shimizu H, Timratana P, Schauer PR, Rogula T. Review of metabolic surgery for type 2 diabetes in patients with a BMI < 35 kg/m(2). J Obes. 2012;2012:147256.

    Article  PubMed  PubMed Central  Google Scholar 

  23. ASMBS position statement: bariatric surgery in class 1 obesity (BMI 30–35 kg/m2). http://asmbs.org/2012/09/bariatric-surgery-in-class-1-obesity-bmi-30-35-kgm2/. Accessed 17 Dec 2012.

  24. Meijer RI, van Wagensveld BA, Siegert CE, Eringa EC, Serné EH, Smulders YM. Bariatric surgery as a novel treatment for type 2 diabetes mellitus: a systematic review. Arch Surg. 2011;146(6):744–50.

    Article  PubMed  Google Scholar 

  25. Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150(6):2518–25.

    Article  PubMed  CAS  Google Scholar 

  26. Lee H, Te C, Koshy S, Teixeira JA, Pi-Sunyer FX, Laferrère B. Does ghrelin really matter after bariatric surgery? Surg Obes Relat Dis. 2006;2(5):538–48.

    Article  PubMed  Google Scholar 

  27. Butner KL, Nickols-Richardson SM, Clark SF, Ramp WK, Herbert WG. A review of weight loss following Roux-en-Y gastric bypass vs restrictive bariatric surgery: impact on adiponectin and insulin. Obes Surg. 2010;20(5):559–68.

    Article  PubMed  Google Scholar 

  28. Laferrère B. Diabetes remission after bariatric surgery: is it just the incretins? Int J Obes (Lond). 2011;35:S22–5.

    Article  Google Scholar 

  29. Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel-Courtin C, Gass M, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012;22(5):740–8.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Unger RH. Lipotoxic diseases. Annu Rev Med. 2002;53:319–36.

    Article  PubMed  CAS  Google Scholar 

  31. Marroquí L, Gonzalez A, Ñeco P, Caballero-Garrido E, Vieira E, Ripoll C, et al. Role of leptin in the pancreatic β-cell: effects and signaling pathways. J Mol Endocrinol. 2012;49(1):R9–17.

    Article  PubMed  Google Scholar 

  32. Meier JJ, Nauck MA. Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes Metab Res Rev. 2005;21(2):91–117.

    Article  PubMed  CAS  Google Scholar 

  33. Rao RS, Yanagisawa R, Kini S. Insulin resistance and bariatric surgery. Obes Rev. 2012;13(4):316–28.

    Article  PubMed  CAS  Google Scholar 

  34. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–84.

    PubMed  PubMed Central  Google Scholar 

  35. Mingrone G, Castagneto-Gissey L. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab. 2009;35:518–23.

    Article  PubMed  CAS  Google Scholar 

  36. Rubino F, R’bibo SL, del Genio F, Mazumdar M, McGraw TE. Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol. 2010;6:102–9.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philip R. Schauer MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schauer, P.R., Aminian, A., Brethauer, S.A. (2015). Operation of Choice for Metabolic Surgery. In: Nguyen, N., Blackstone, R., Morton, J., Ponce, J., Rosenthal, R. (eds) The ASMBS Textbook of Bariatric Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1206-3_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1206-3_29

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1205-6

  • Online ISBN: 978-1-4939-1206-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics